By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ViiV Healthcare 

Five Moore Drive

Research Triangle Park  North Carolina  27709-3398  U.S.A.
Phone: 877-844-8872 Fax: n/a


Company News
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE)'s ViiV Healthcare Wins Approval For HIV Combo Drug 8/22/2014 4:16:49 PM
ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3 7/22/2014 11:58:34 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Joins Johnson & Johnson (JNJ)'s Janssen Research & Development To Develop Single-Pill HIV Drug 6/12/2014 6:50:49 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014 7:33:44 AM
ViiV Healthcare Release: Tivicay® (dolutegravir) Receives Positive CHMP Opinion In Europe For The Treatment Of HIV 11/22/2013 10:29:30 AM
ViiV Healthcare Presents Positive Data From Phase 3b/4 Study of Dolutegravir Vs Darunavir in Treatment-Naive Adults With HIV-1 9/13/2013 7:12:44 AM
GlaxoSmithKline (GSK) Says No Plan for ViiV Healthcare Spinoff "at the Moment" 1/10/2013 7:33:50 AM
ViiV Healthcare Says Phase III Data From VIKING-3 Dolutegravir Study Encouraging 11/14/2012 7:19:13 AM
Shionogi, Inc.-ViiV Healthcare to File HIV Drug dolutegravir for Approval 10/4/2012 7:27:29 AM
ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment 7/18/2012 11:43:25 AM